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[57] ABSTRACT 
A method for increasing the tenderness of livestock meat 
tissues. The method involves increasing the calcium con-
centration in livestock muscle tissue prior to harvest of the 
animal to a degree sufficient to activate or enhance post-
mortem tenderization mechanisms. This is accomplished, 
most preferably, through the administration of Vitamin D, its 
analogs or derivatives, or combinations thereof, to livestock 
at concentrations above those required nutritionally in order 
to decrease shear force (increase tenderness) of meat tissues. 




























--o-- 2.5 MIU/D 
----6- 5.0MIU/D 
---~ 7.5 MIU/D 
\.I_/ .38 .04 .41 .07 .03 .02 .01 
.46 .03 .16 .07 .01 .01 .01 
DAYS DOSED 
1 2 3 4 5 6 7 8 
TIME ON TRIAL (DAYS) 
I 
I 
.04 .02 .01 








.01 .01 .09 .01 I DOSE EFFECT 
.01 .02 .23 .01 I LINEAR RESPONSE 
( PROBABILITY LEVEL, P < ) 







~ = ...... 
0 














METHODS FOR IMPROVING MEAT 
TENDERNESS 
This application claims the benefit of copending U.S. 
Provisional Patent Application Ser. No. 60/053,769, filed 25 5 
Jul. 1997. 
BACKGROUND OF THE INVENTION 
1. Field of Invention 
2 
can reach 100 µM as a result of the release of calcium ions 
from mitochondrial and sarcoplasmic reticulum reserves. 
Previous studies (Koohmaraie et al., 1987; Vidalenc et al., 
1983; Ducastaing et al., 1985) have indicated that under 
normal postmortem conditions, m-calpain is remarkably 
stable, whereas there is a gradual decline in the activities of 
µ-calpain, and calpastatin loses its activity rapidly. Bothµ-
and m-calpain undergo autolysis in the presence of sufficient 
calcium with the eventual loss of activity (Suziki et al., 
The present invention relates generally to improving the 
tenderness of meat, and, more specifically, to methods for 
improving meat tenderness through the use of hypercalce-
mic agents to activate or enhance postmortem tenderization 
mechanisms. 
10 1981; DeMartino et al., 1986; Koohmaraie et al., 1989). 
2. Background 
Recent surveys have indicated that an excessive amount 
of variation exists in the tenderness of beef cuts at the retail 
and food service levels (Morgan et al., 1991; Hamby, 1992). 
15 
Secondly, elevation of calcium, which results in accelerated 
postmortem proteolysis and tenderization process, also 
accelerates the process of calpastatin inactivation 
(Koohmaraie et al., 1988; 1989). 
Attempts have been made to elevate muscle calcium 
concentrations through dietary calcium supplementation 
and/or infusion of a calcium chloride solution to a live 
animal, but since blood calcium homeostasis is regulated 
very closely (8-12 mg/dL in cattle) these attempts have 
resulted in limited success. Accordingly, prior methods 
proposed for improving tenderness generally have involved 
mechanical, chemical or enzyme application to the meat 
tissue. Such systems are costly and raise consumer concerns 
about food adulteration and allergic reactions. Pre-harvest 
infusions of calcium mixtures directly into the blood stream 
immediately pre-slaughter will improve meat tenderness, 
but such administration is complex to control. 
In fact, the latest National Beef Quality Audit ranked inad- 20 
equate tenderness as the second most important beef quality 
problem (Smith et al., 1995). It is estimated that the annual 
economic loss associated with beef toughness equals $7.64 
per animal or $217.0 million to the U.S. beef industry. Thus, 
the National Cattlemen's Beef Association (NCBA, 1995) 25 
listed development of a procedure or instrument that can 
improve and/or predict beef tenderness as a high-priority 
issue within the U.S. beef industry. 
It is accordingly an object of the present invention to 
provide a method for increasing the tenderness of livestock 
30 meat tissues that is easy to accomplish, commercially 
practicable, and which does not raise consumer concerns. 
In the past, attempts at tenderizing meat have involved 
extended holding times or aging of meat postmortem in a 
controlled, refrigerated environment. Davey and Gilbert 
(1969) first provided evidence that associated the involve-
ment of calcium ions with the process of postmortem aging 
of meat. Busch et al. (1972) later demonstrated that the 
presence of calcium induced myofibril fragmentation and 35 
that process in turn was hindered by the addition of a 
calcium chelator. Many subsequent efforts have focused on 
the relationship between postmortem storage and the activi-
ties of the calpain protease system (i.e.,µ- and m-calpain and 
their endogenous inhibitor, calpastatin) (for review see 40 
Koohmaraie, 1992). Because the activity of m-calpain 
remains nearly constant throughout postmortem storage, and 
there is a progressive decrease in the activity of µ-calpain, 
Koohmaraie et al. (1987) suggested that µ-calpain, not 
m-calpain, was involved in postmortem aging. However, 45 
when sufficient calcium ions are present, both calpain pro-
teases are activated and each undergoes autolysis. Therefore, 
the rapid loss of µ-calpain during postmortem storage 
(Koohmaraie et al., 1987) is a good indicator that µ-cal pain, 
unlike m-calpain, is activated during normal postmortem 50 
conditions. Koohmaraie et al. (1989) validated this theory 
when ovine carcasses infused with calcium chloride solution 
produced meat which was tender after only 1 day of post-
mortem aging. These results led to the development of the 
calcium-activated tenderization (CA1) system in which pre- 55 
rigor or postrigor meat is injected with a calcium chloride 
solution, which in turn activates the both calpain proteases 
and results in enhanced meat tenderness (Wheeler et al. 
1991, 1992, 1993, 1994, and 1997). 
BRIEF SUMMARY OF THE INVENTION 
The present invention provides a method for increasing 
the tenderness of livestock meat tissues which achieves the 
desired objectives. It involves increasing the calcium con-
centration in livestock muscle tissue prior to harvest of the 
animal to a degree sufficient to activate or enhance post-
mortem tenderization mechanisms. This is accomplished, 
most preferably, through the administration of Vitamin D, its 
analogs or derivatives, or combinations thereof, to livestock 
at concentrations above those required nutritionally in order 
to decrease shear force (increase tenderness) of meat tissues. 
As it relates to beef cattle, the most preferred embodiment 
comprises administering 100,000 to 1,000,000 IU of Vita-
min D3 per kilogram of diet consumed (1-10 million IU 
daily) to finishing steers for up to 10 days immediately prior 
to harvest in order to obtain the desired results. 
Studies were undertaken in connection with the present 
invention to determine 1) the effectiveness of supplemental 
vitamin D3 (VITD3 ) on altering plasma and muscle calcium 
levels, 2) whether VITD 3 supplementation decreases 
Warner-Bratzler shear (WES) force values of steaks from 
feedlot beef steers, and 3) the tenderness response curve in 
VITD3 supplemented longissimus muscle steaks. In Experi-
ment 1, 20 crossbred steers were assigned randomly to one 
of four treatment diets consisting of either 0, 2.5, 5.0 or 7.5 
million IU of VITD3 per day for 10 days. Blood samples 
Currently, there is a debate on how calpain proteases 
could possibly function in muscle tissue since the calcium 
requirements for proteolytic activity of these enzymes 
(approximately 10 µM for µ-calpain and approximately 
200---300 µM for m-calpains) are much higher than the free 
calcium concentrations found in living muscle tissue ( <1 
µM). While the concentration of free calcium in resting 
muscle is low, postmortem muscle calcium concentrations 
60 were obtained daily during this supplementation period and 
5 days thereafter (days 11-15). Results suggested that 
between day 6 through day 13 a linear increase (P<0.01) in 
ionized plasma calcium concentrations was observed in 
steers supplemented with VITD 3 . Compared to non-
65 supplemented steers, ionized plasma calcium concentrations 
of the steers receiving 7.5 million IU of VITD3 per day were 
increased between 30% and 50%. In Experiment 2, longis-
5,968,565 
3 
simus dorsi samples from crossbred steers (n=118) which 
were supplemented with either 0 or 5 million IU of VITD3 
per day for 7 days were obtained and aged for 7, 14, or 21 
days. Following the initial 7-day postmortem aging period, 
VITD3 supplementation lowered (P<0.01) WES valves 5 
(0.58 kg) and increased sensory tenderness rating (0.6 units) 
when compared to cuts originating from non-supplemented 
steers. In Experiment 3, 44 steers were supplemented with 
either 0 or 7.5 million IU of VITD3 per day for 10 days 
immediately prior to harvesting. Results indicated that 1) 10 
plasma and longissimus dorsi calcium concentrations were 
higher (P<0.05) for steers that received supplemental 
VITD3 ; 2) compared with non-supplemented cuts, VITD3 
supplementation decreased WES valves of cuts aged for 7-, 
14- and 21-days (P<0.02, P<0.07 and P<0.13, respectively); 15 
and 3) sensory panelists preferred samples from VITD3 
supplemented steers. Activation of calpain proteases may be 
responsible for the observed tenderization due to the supple-
mentation of VITD 3 . 
4 
calcium concentration by stimulating intestinal calcium 
absorption (Nicolaysen, 1937), mobilizing calcium from 
previously formed bone mineral (Carlsson, 1952), and 
through 1,25-dihydroxyvitarnin D3 which increases renal 
reabsorption of calcium from the kidney (Sutton and Dirks, 
1978). In fact, it has been shown that a relationship between 
low blood serum calcium levels and the activation of 1,25-
dihydroxyvitamin D3 exists in that feeding low calcium diets 
stimulated the formation of 1,25-dihydroxyvitamin D3 
which in turn promoted the mobilization of calcium from 
bones (DeLuca, 1979; Sutton et al., 1977; Kleeman et al., 
1961). Mobilizing calcium as a result of Vitamin D admin-
istration has been performed as a means to prevent parturient 
paresis in lactating dairy cows. It was concluded that orally 
administered vitamin D at 5 million IU daily for 2 weeks 
prepartum increased serum calcium 2.1 mg/dL compared to 
control animals (Hibbs et al., 1951). Hibbs and Pounden 
(1955) observed that oral supplementation of 5, 10, 20 and 
30 million IU of vitamin D for 3 to 8 days prepartum 
A better understanding of the present invention and its 
objects and advantages will become apparent to those skilled 
in this art from the following detailed description, taken in 
conjunction with the attached figure, wherein there is shown 
and described only the preferred embodiments of the 
invention, simply by way of illustration of the best mode 
contemplated for carrying out the invention. As will be 
realized, the invention is capable of modifications in various 
obvious respects, all without departing from the invention. 
Accordingly, the description should be regarded as illustra-
tive in nature and not as restrictive. 
20 increased serum calcium concentrations by 1.9, 1.0, 1,9 and 
2.3 mg/dl, respectively. Single injections of 
la-hydroxyvitamnin D3 (500 or 700 µg) alone or in combi-
nation with 25-hydroxyvitamin D3 ( 4 mg) increased serum 
calcium concentrations 1.8 to 2.4 mg/dL 3 to 8 days after 
BRIEF DESCRIPTION OF THE DRAWINGS 
The Figure is a graphical representation of the temporal 
effects of vitamin D3 supplementation (0, 2.5, 5.0 or 7.5 
million IU/day) on ionized blood calcium concentration of 
steers in Experiment 1. Probabilities represent significance 
levels of the plasma response to vitamin D3 (dose effect) and 
of the linear response to vitamin D3 dosage (linear 
response). 
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENT 
Before explaining the present invention in detail, it is 
important to understand that the invention is not limited in 
25 injection (Bar et al., 1985, 1988; Sachs et al., 1987; Hodnett 
et al., 1992). 
In addition to mobilizing calcium, it has recently been 
discovered that VITD3 stimulates the influx of calcium in 
skeletal muscle cells through the activation of calcium 
30 channels. Vazquez et al. (1997) performed a series of experi-
ments and concluded that calcium release-activated calcium 
channels participate in the rapid modulation of calcium entry 
in animal cells by 1,25-dihydroxyvitamin D3 . It appears that 
VITD3 and its derivatives actually stimulate calcium mobi-
35 lization as well as its entry in skeletal muscle cells. 
The desirability of providing cattle with increased cal-
cium is discussed in U.S. Pat. No. 5,393,595 to Kjems. 
Kjems discusses a composition containing a calcium ion 
which comprises a water-in-oil emulsion which is orally 
40 administrable and palatable to cows for preventing milk 
fever. The composition further comprises a calcium salt that 
is dissolved in the aqueous phase to form an aqueous phase 
solution containing a calcium ion. The invention also 
includes the method of orally administering the composition 
45 to cows to treat milk fever. its application to the details and steps described herein. The 
invention is capable of other embodiments and of being 
practiced or carried out in a variety of ways. It is to be 
understood that the phraseology and terminology employed 
herein is for the purpose of description and not of limitation. 50 
The concept of providing animals with high dosages of a 
Vitamin D3 metabolite for increasing calcium utilization so 
that less dietary calcium is required is discussed in U.S. Pat. 
Nos. 5,366,736 and 5,516,525 to Edwards, Jr. Additionally, 
the benefits of providing animal feed compositions with a 
Vitamin D metabolite for the purpose of promoting eggshell 
and bone strength in egg-laying hens is discussed in U.S. 
Pat. No. 5,043,170 to Bornstein et al. 
The preferred embodiment of the invention improves 
meat tenderness in animals through increasing the free 
calcium concentration in muscle in an animal prior to 
harvest to a degree sufficient to activate or enhance post-
mortem tenderization mechanisms, i.e., to a degree 55 
sufficient, it is believed, to active both µ-calpain and 
m-calpain proteases. In the most preferred aspect of the 
invention, the free calcium concentration in muscle is 
increased by administering to the animal for a time prior to 
harvest an amount above that required nutritionally of 60 
Vitamin D, analogs or derivatives of Vitamin D, or combi-
nations thereof, and, particular, the form of Vitamin D 
known as Vitamin D3 . 
While others have investigated providing cattle with 
increased calcium, or increasing calcium utilization through 
Vitamin D supplementation, for the purpose of, among other 
things, preventing milk fever in cattle or parturient paresis in 
lactating dairy cows, the pre-harvest administration of Vita-
min D3 to beef cattle in amounts above that required 
nutritionally for a time period sufficient to activate or 
enhance postmortem tenderization mechanisms presents a 
novel approach to improving meat tenderness. 
Vitamin D is known as the "sunshine vitamin" because 
the skin synthesizes cholecalciferol (vitamin D3 or 
"VITD3") when exposed to ultraviolet light. Previous 
research has demonstrated that VITD3 increases plasma 
As used herein the phrase "in an amount above that 
65 required nutritionally" means an amount more than that 
amount defined by the National Research Council as being 
required nutritionally in an animal's diet. For beef cattle, this 
5,968,565 
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figure is about 275 IU per kilogram of diet. An amount more 
that 500 IU per kilogram of diet for any animal should be 
considered for the purpose of the present invention to be an 
amount above that required nutritionally. 
Vitamin D3 , or cholecalciferol, is normally synthesized in 
the skin of animals and people from an inactive precursor, 
7-dehydrocholesterol, by reactions that are promoted by 
exposure to the ultraviolet component of sunlight. It is also 
abundant in fish-liver oils. The other common form is 
Vitamin D2 , or ergocalciferol, a commercial product made 
by ultraviolet irradiation of ergosterol of yeast. Vitamin D3 
itself is not biologically active, but it is the precursor of, 
among other metabolites, 1,25-dihydroxycholecalciferol. 
Vitamin D3 is metabolized first by the hydroxylation at the 
C25 position to 25-hydrocholecalciferol by one or more liver 
enzymes, followed by the hydroxylation of 
25-hydrocholecalciferol at the C1 position to 1,25-
dihydroxycholecalciferol ( also known as calcitriol) by one 
or more enzymes present in the kidneys. As used herein, the 
term "Vitamin D," when left unqualified, means either of the 
two commons forms of the vitamin. The term "analog" as 
used herein in reference to Vitamin D refers to chemical 
compounds structurally similar to either of the common 
forms of Vitamin D but which differ slightly in composition 
( as in the replacement of one atom by an atom of a different 
element or in the presence of a particular functional group). 
The term "derivative" as used herein in reference to Vitamin 
D refers to chemical substances related structurally to the 
two common forms of Vitamin D and theoretically derivable 
from it. More particularly, the term "derivative" includes 
hydroxylated metabolites of Vitamin D, and specifically 
Vitamin D 3 , such as 1-hydroxycholicalciferol, 
25-hydrocholecalciferol, 1,25-dihydroxycholecalciferol, 
24,25-dihydroxycholecalciferol, 1,24,25-




An effective dosage of Vitamin D, its analogs or 
derivatives, or combinations thereof, for the enhancement of 
meat tenderness is an amount which is above that required 
nutritionally and which activates or enhances postmortem 
5 tenderization mechanisms. The dosage is preferably fed to 
an animal in a feed composition for a predetermined time 
prior to harvest. To ensure consumption of the entire dosage, 
the animal may be fed a lesser volume diet during the 
supplementation period. It will be understood by those 
10 skilled in the art that the supplement could also be admin-
istered as a water supplement or by injection, but for 
convenience intake with feed compositions is preferred. 
The primary use of the present invention is believed to 
reside in the pre-harvest treatment of beef cattle, although 
15 the invention is not limited to use with this animal, and, in 
its most preferred embodiment involves the oral adminis-
tration of Vitamin D, its analogs or derivatives, and combi-
nations thereof, for a time prior to harvest in an amount 
above that required nutritionally for beef cattle. The accept-
20 able dosage range to achieve the desired results in beef cattle 
is believed to be between 100,000 and 1,000,000 IU per 
kilogram of diet consumed, or, expressed as a daily intake, 
1-10 million IU daily. The length of time in which the 
dosage should be administered is dependent upon both the 
25 dosage amount and the method of administration. For the 
preferred oral administration and without limiting the 
breadth of this present invention, 3 days of the preferred 
dose most likely constitutes the minimum length of 
administration, while lower doses may be administered over 
30 the course of a month or longer. When administered 
parenterally, however, desired results may be achieved in six 
hours or less in some cases. More specifically, the most 
preferred embodiment for beef cattle encompasses admin-
istering a dosage of 100,000 to 1,000,000 IU of Vitamin D3 
35 per kilogram of diet (1-10 million IU daily) to an animal for 
up to 10 days prior to harvest. Administration of this dosage 
at this dosing schedule has been shown to activate or 
enhance postmortem tenderization mechanisms thereby The Vitamin D3 derivatives described herein can be 
prepared by known procedures, including the teachings of 
the following references which are mentioned in Cols. 5 and 40 
6 of U.S. Pat. No. 5,366,736 and which are incorporated 
herein by reference: 1,25-dihydroxycholecalciferol can be 
prepared as described in Biochemistry 10(14), 2799 (1971), 
and U.S. Pat. Nos. 4,310,467 and 3,697,559; 1,25-
dihydroxy-26,27-hexadeuterocholecalciferol can be pre-
pared as described for the synthesis of 1,25-
dihydroxycholecalciferol in Tet. Let. 40, 4147 (1972), with 
the substitution of a trideuteromethyl Grignard reagent in 
place of the methyl Grignard reagent used to add the carbons 
improving meat tenderness. 
The preferred agent for oral administration is a feedstuff 
constituting grower or finishing rations and containing 100, 
000 to 1,000,000 IU per kilogram of Vitamin D, its analogs 
or derivatives or combinations thereof. Grower or finishing 
rations means typical feedlot feedstuffs including roughages, 
45 such as hay or silage, and concentrates such as grains ( corn, 
barley, milo, rye, oats and wheat), and mixtures thereof, 
along with molasses and other supplements and additives. 
The present invention will be further understood with 
50 
reference to the following non-limiting experimental 
examples. 
at the 26 and 27 positions; 1-hydroxycholecalciferol can be 
prepared by the methods described in J. Am. Chem. Soc. 
95(8), 2748 (1973) and U.S. Pat. No. 3,741,996; 1,24,25-
trihydroxycholecalciferol can be prepared by the method 
described in U.S. Pat. No. 3,847,955; 1,25-dihydroxy-24-
fluorocholecalciferol can be prepared by the procedure 55 
described in J Org. Chem., 53(5), 1040 (1988); 
25-hydroxycholecalciferol can be prepared as described in 
U.S. Pat. Nos. 4,310,467 and 3,565,924. The chemical 
structures of 7-dehydrocholesterol, Vitamin D 3 
( cholecalciferol), 1,25-dihydroxycholecalciferol ( calcitriol), 60 
1-hydroxycholicalciferol, 25-hydrocholecalciferol, 24,25-
d i hydroxy ch o le ca lc if e ro l, 1,24,25-
trih ydro xycho le calciferol, 1,25-dihydroxy-
24-fluorocholecalciferol, and 1,25-dihydroxy-26,27-
hexadeuterocholecalciferol are shown in FIGS. 2 and 3 of 65 
U.S. Pat. No. 5,366,736, said patent and figures also being 
incorporated herein by reference. 
Experimental Examples 
An Animal Use and Care Committee approved the use 
and treatment of animals in these studies according to 
guidelines established by Oklahoma State University. 
Experiment 1: Twenty crossbred steers (550 kg mean 
weight) were assigned randomly to one of four treatments. 
Steers were individually fed 1.5% of their body weight and 
supplemented with 0, 2.5, 5.0 or 7.5 million IU of vitamin 
D3 per day for 10 days with 5 steers per dose level. Blood 
samples were obtained daily during this supplementation 
period and 5 days thereafter. Blood plasma samples were 
analyzed for ionized calcium using a Orion calcium ion 
selective electrode (Orion Research, Boston, Mass.). Ionized 




Experiment 2: Two sets of crossbred steers (n=20, Angusx 
Hereford F 1 crossbreds and n=98, Sale rs or Charolais sire to 
Brangus dams) had ad libitum access to a high-energy 
density diet for 140 days before slaughter. One-half of the 
steers were supplemented with 5 million IU of vitamin D3 
per day for 7 days immediately prior to harvesting. The 
steers were harvested using an approved humane technique, 
and plasma from blood samples obtained during exsan-
guination were analyzed for calcium, magnesium, 
triglyceride, glucose, chlorine, phosphorus, sodium and 
potassium using a Roche Cobas Mira device (Roche Diag-
nostic Systems, Nutley, N.J.). Following a 36 hour chilling 
period ( at -1 ° C.), carcasses were ribbed and USDA quality 
and yield grade information were recorded. After collection 
of grade information, one strip loin was removed from each 
carcass. Five steaks (2.54 cm thick) were fabricated from 
each strip loin subprimal. The first steak was aged for 7 days 
postmortem and used for trained sensory evaluation, the 
second, third and fourth steaks were aged for 7, 14 and 21 
days, respectively, and used for Warner-Bratzler shear force 
determination and the fifth steak was used for total muscle 
calcium determination. The steaks used for Warner-Bratzler 
shear force and sensory panel determinations were individu-
ally packaged and frozen at -20° C. For each trait, only the 
longissimus dorsi was evaluated. 
Steaks for Warner-Bratzler shear force and sensory evalu-
ation were thawed to 2° C. then broiled on an impingement 
oven to an internal temperature of 70° C. Warner-Bratzler 
shear force was conducted as described by Wheeler et al. 
(1995). The cooked steaks were cooled to 20° C., and then 
six 1.27-cm-diameter cores were removed parallel to the 
muscle fiber orientation. Cores were sheared once each on 
an Instron Universal Testing Machine model 1135 (Instron, 
Canton, Mass.) with a standard Warner-Bratzler attachment 
and 5 cm/min crosshead speed. 
Cooked steaks for trained sensory evaluation were held at 
70° C. for up to 10 minutes before they were cut into 1 cmxl 
cmxl cm cubes and served warm to an eight-member 
sensory panel trained according to Cross et al. (1978). Each 
panelist independently evaluated two cubes from each 
sample for juiciness, beef flavor intensity, tenderness, and 
connective tissue amount using 8-point scales (8=extremely 
juicy, intense, tender, none; l=extremely dry, bland, tough, 
abundant) and off-flavor on a 4-point scale ( 4=none, 
l=intense). Scores for each sample were the mean of the 
scores for all eight panelists. Each session was initiated with 
a warm-up sample. 
8 
were then centrifuged, filtered, and dialyzed overnight ( 40 
mM Tris, 5 mM EDTA, and 10 mM MCE, pH 7.5). After 
dialysis the samples were centrifuged, filtered, and loaded 
gravimetrically onto anion-exchange columns (DEAE-
5 Sephacel; Sigma Chemical, St. Louis, Mo.). The columns 
were washed with elution buffer (50 mM Tris, 1 mM EDTA, 
and 10 mM MCE, pH 7.5) and eluted using a linear NaCl 
gradient (25 to 350 mM) in elution buffer. Activities of the 
calpains were determined using a casein solution (100 mM 
10 
Tris, 1 mM NaN3 , 5 mM CaC12 , 5 mg/mL casein, and 1 
µL/mL MCE, pH 7.5). One unit of calpain activity was 
defined as the amount of enzyme necessary to cause an 
increase of 1.0 optical density unit at 278 nm in 1 hour at 25° 
C. Quanitification of calpastatin was accomplished using a 
slightly modified procedure developed and verified by 
15 Shackelford et al. (1994). Briefly, a 5 g longissimus muscle 
sample was extracted in 20 mL of extraction buffer (150 mM 
TRIS, 10 mM EDTA, and 7 mM MCE, pH 8.3) by homog-
enizing for 3x30 seconds with a polytron with a 30-second 
rest between each burst. The homogenate was centrifuged 
20 for 1 hour at 30,000xg and the supernatant fluid was filtered 
through cheesecloth. The supernatant fluid was transferred 
into 13- xlO0-mm borosilicate test tubes and heated in a 
water bath (95° C.) for 15 min to denature calpains. Fol-
lowing heating, samples were chilled on ice for 15 minutes. 
25 Following centrifugation (for 30 minutes at 6,000xg.), the 
volume of supernatant fluid was determined and recorded 
for subsequent calculation of calpastatin. One unit of calp-
astatin activity was defined as the amount of inhibitor 
necessary to inhibit one unit of DEAE-purified m-calpain 
30 activity. 
Statistical Analysis: For blood plasma calcium concen-
tration data from Experiment 1 single df contrasts were used 
to determine effects of supplementing VITD 3 and whether 
the response was linearly related to dosage. Samples from 
35 Experiment 2 were considered to be blocked by set of steers 
(Set 1 and 2) and breed of sire (Salers or Charolais sire in set 
2). Lavene's test was performed to test for heterogeneity of 
variances among the group by treatment combinations. 
Variance was not heterogeneous according to that test. 
40 Levene's test was performed to test for heterogeneity of 
variances among 12 groups by treatment combinations. 
Variance was not heterogeneous according to that test. 
Carcass and palatability data were analyzed using the gen-
eral linear model procedure of SAS (1985) using pen 
45 (rep*treatment) as the error term. For Experiment 3, harvest 
date was considered as two blocks. The mixed model 
procedure of SAS (1985) was used to analyze carcass, 
palatability and protease. Total calcium content of muscle samples was measured 
using procedures described by Nakamura (1973). Upon 
50 
completion of the digestion process, the amount of Ca2 + was 
measured with an atomic absorption spectrophotometer 
(Model D 951, Lexington, Mass.). 
Results 
The principle objective of Experiment 1 was to determine 
if VITD3 supplementation altered blood calcium concentra-
tions compared to levels from non-supplemented steers. 
Mean concentrations of ionized blood calcium from VITD3 Experiment 3: Forty-four crossbred steers were supple-
mented with either 0 or 7.5 million IU VITD per day for 10 
days immediately prior to harvesting humanely. Blood and 
strip loin samples were collected from each carcass and 
processed as described in Experiment 2. 
At 24-hours postmortem, activities of µ-calpain, 
m-calpain and calpastatin were determined on unfrozen 
longissimus muscle according the procedures of Koohma-
raie (1990) with slight modifications. To determine calpain 
protease activities, longissimus samples (20 g) were homog-
enized in 2.5 vol of extraction buffer (50 mM Tris, 10 mM 
EDTA and 30 mM ~-mecaptoethanol [MCE], pH 8.3) and 
shipped on ice to the Food Processing Center at Oklahoma 
State University for measurements of calpains. The samples 
55 supplemented steers plotted as a percentage of those of 
control steers are shown in FIG. 1. As a result of VITD3 
supplementation, blood ionized calcium increased linearly 
(P<0.04) between day 6 and day 13. This noticeable increase 
in blood ionized calcium level was additionally observed 
60 (P<0.01) on day 15 for steers which were supplemented with 
VITD3 . Steers supplemented with 7.5 million IU of VITD3 
per day exhibited blood calcium levels that were between 
40% to 50% greater when compared to calcium levels from 
non-supplemented control animals. These results are similar 
65 to earlier studies which involved the supplementation of 
VITD3 aiding the prevention of parturient paresis in lactat-
ing dairy cows (Hibbs et al., 1951). 
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Sample statistics of carcass characteristics as impacted by 
VIID3 supplementation of both Experiments 2 and 3 are 
presented in Table 1. Because VITD3 supplemented steers in 
the two studies were only treated for a 7- or 10-days period 
prior to harvesting, respectively, carcasses from each experi- 5 
ment had similar (P>0.05) mean values for all carcass traits. 
It should be mentioned that the carcasses sampled in Experi-
ments 2 and 3 had carcass characteristics similar to those as 
evaluated in the National Beef Quality Audit (Boleman et 10 
al., 1998). 
TABLE 1 
Least squares means for the main effect of treatment on sample carcass 15 
traits from Vitamin D3 supplemented steers in Experiments 2 and 3 
Trait Control VITD3 SEM (P<) 
TABLE 2 
Least squares means for blood plasma samples 
for steers supplemented with either O or 5 million 
IU of Vitamin 0 3 for 7 days prior to slaughter. 
Treatment 
Item Control VITD3 SEM 
Steers, n 10 10 
Ca, mg/dL 9.23 12.39 0.29 
Mg, meq/L 1.99 1.46 0.06 
Triglyceride, mg/dL 22.5 26.9 2.20 
Glucose, mg/dL 153.6 200.2 38.0 
Cl,mM 103.6 104.0 1.1 
P, mg/dL 6.66 6.36 0.15 
Na,mM 149.2 148.0 1.5 
K,mM 7.22 6.77 0.44 









VITD3 supplementation (5.0 million IU per day for 7 
Experiment 2a 
Steers, n 59 
Carcass weight, kg 336.2 
Adj. fat thickness, cm 1.03 








20 days) resulted in elevated (P<0.05) muscle calcium concen-
tration (µgig of wet tissue) compared with control muscle 
tissue (Table 3). Longissimus muscle cuts from VITD3 -
supplemented animals displayed improved (P<0.01) shear 
force values at days 7 compared with cuts from control 
86.2 84.1 0.80 .08 
Internal (KPH) fat, % 1.9 1.8 0.06 .39 
USDA Yield Grade 2.40 2.40 0.08 .91 
Skeletal Maturityc 148 146 2.4 .43 
Lean Maturity" 136 140 2.4 .30 
Marbling scoree 300 295 9.0 .70 
Experiment 3b 
Steers, n 22 22 
Carcass weight,kg 358.5 368.4 7.6 .38 
Adj. fat thickness, cm 1.00 1.00 .10 .15 
Longissimus area, cm 92.5 90.0 2.5 .50 
Internal (KPH) fat, % 2.0 2.3 .17 .20 
USDA Yield Grade 2.2 2.6 .19 .09 
Skeletal Maturityc 130 125 3.95 .35 
Lean Maturityct 185 178 10.9 .62 
Marbling scoree 384 434 18.0 .06 
'Animals fed vitamin D were supplemented with 5 million IU per day for a 
total of 7 days 
b Animals fed vitamin D were supplemented with 7.5 million IU per day for 
25 
carcasses. However, no differences (P>0.05) in shear force 
rating were noticed when meat samples were aged for 14 or 
21 days postmortem. To compare the two supplementation 
groups with respect to their conformance to desired speci-
fications for beef tenderness, a threshold value of 4.6 kg was 
30 chosen for shear force value (Shackelford et al., 1991a), 
recognizing that absolute shear force values may differ 
between research locations. Data showing the percentage of 
steers in each group failing to meet this criterion after 7, 14 
or 21 days of postmortem aging are presented in Table 3. 
35 After 7 days of postmortem aging, approximately half 
(56.0%) of all control cuts failed to meet the shear force 
threshold compared to approximately a third (34.2%) of the 
strip loin cuts from VITD3 supplemented steers. However, 
extending the postmortem aging time to either 14 or 21 days 
40 negated (P>0.05) any advantageous effect associated with 
VITD3 supplementation. 
TABLE 3 
a total of 10 days 45 
Least squares means for the main effect of treatment on longissimus 
muscle calcium content, Warner-Bratzler shear force, and sensory 
traits of vitamin D3 supplemented steers from Experiment 2. 
cskeletal maturity: 100 to 199 - A maturity. 
ctLean maturity: 100 to 199 - light cherry red, fine in texture. 
'Marbling score: 300-399 and 400-499 - "slight" and small degree of 
marbling, respectively. 
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As was the case in Experiment 1, blood plasma profile 
results from Experiment 2 indicated that VITD3 supplemen-
tation elevated (P<0.03) calcium concentration compared to 55 
non-supplemented controls (Table 2). It should be high-
lighted that once again a similar increase (approximately 
20%) in blood calcium concentration was observed when 5 
million IU of VIID3 were supplemented to finishing steers 
7 days prior to their scheduled harvest date. In addition to an 60 
elevation in calcium concentrations, VITD3 supplementa-
tion resulted in decreased (P<0.001) magnesium levels com-
pared to non-supplemented controls. No differences 
(P>0.05) were observed for blood plasma triglyceride, 65 
glucose, chloride, phosphorous, sodium or potassium levels 
between VITD3 supplemented and control steers. 
Treatment 
Item Control VITD3 SEM (P < 1) 
Steers, n 59 59 
Ca, µgig 13.9 19.9 2.7 .05 
Shear force, d 7 4.70 4.12 .08 .01 
Shear force, d 14 4.03 3.87 .09 .25 
Shear force, d 21 3.58 3.60 .11 .90 
Shear force > 4.6 kg, d 7 56.0 34.2 5.5 .01 
Shear force > 4.6 kg, d 14 20.0 17.0 7.2 .78 
Shear force > 4.6 kg, d 21 6.0 8.0 4.8 .77 
Juiciness8 5.46 5.76 .14 .31 
Tendernessa 4.77 5.53 .06 .02 
Connective tissue amount 7.04 6.99 .07 .54 
Beef flavor intensitt 5.84 6.02 .11 .28 
Off-flavorb 3.88 3.75 .03 .78 
ag = extremely juicy, tender, none detected, intense to 1 = extremely dry, 
tough, abundant arnount, bland. 
b4 = none detected to extreme off-flavor. 
In the present study, VIID3 supplementation had a highly 
significant (P<0.02) effect on trained sensory tenderness 
ratings (Table 3). Compared to the "slightly-tender" panel 
5,968,565 
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tenderness ratings received by steaks from VITD3 supple-
mented carcasses, strip loin steaks from control carcasses 
received "slightly-tough" ratings. No detectable differences 
(P>0.05) were observed in sensory scores related to 
juiciness, connective tissue amount, beef flavor intensity and 5 
off-flavor were detected between steaks from VITD3 supple-
mented and control carcasses. 
In Experiment 3, VITD3 supplementation (7.5 million IU 
per day for 10 days) to finishing steers resulted in elevated 
(P<0.02) muscle calcium concentration compared to non- 10 
supplemented tissue levels (Table 4). Strip loin cuts from 
VITD3 supplemented cattle displayed day 7 shear force 
values approximately 1 kg lower (17.9% reduction) than 
those of control cuts. As a result of a higher VITD3 dosage 
level (5 million versus 7.5 million IU per day) as well as an 15 
extended supplementation period (7 days versus 10 days), 
beef tenderness benefits from Experiment 3 tended (P<0.10) 
to remain apparent even following extended postmortem 
aging periods of 14 and 21 days postmortem. This was 
evident due to a reduction in shear force (approximately 0.6 20 
kg) and by the improved percentage of steaks from carcasses 
of VITD3 supplemented steers meeting the shear force 
conformance specification of 4.6 kg (Table 4). 
12 
amount of free calcium corresponds to 0.53-mM calcium 
distributed in the muscle. This concentration should be 
sufficient to activate both µ-cal pain and m-calpain ( Goll et 
al., 1985) and subsequently improve meat tenderness. From 
a very general point of view, it appears that VITD3 supple-
mentation may improve longissimus muscle tenderness and 
palatability traits in a mild but similar rendition of the CAT 
(i.e., calcium-activated tenderization) system. It appears that 
VITD3 induced tenderization of meat is probably due to 
activation of calpain proteases, but other possible mecha-
nisms cannot be ruled out. 
In addition to supplying Vitamin D or its analogs or 
derivatives in food or water or by injection, other hypercal-
cemic agents or methods to induce hypercalcemia or 
elevated blood and muscle calcium concentrations might be 
used to obtain a similar result. These methods include 
altering the acid-base balance of blood through altering the 
dietary supply of an animal; absorption or retention of 
sodium through altering the dietary supply of an animal; and 
absorption or retention of sodium, potassium, chloride bicar-
bonate and sulfur. An additional method includes feeding 
specific plants that are naturally rich in or enriched with 
Vitamin D or its analogs, such as Solanum Malacoxylon, 
Trisetum Flavescens, or irradiated yeast. Additionally, alter-
TABLE 4 
Least squares means for the main effect of treatment on longissimus 
muscle calcium content, Warner-Bratzler shear force, and calpastatin 
activities of vitamin D3 supplemented steers from Experiment 3. 
25 ing blood concentrations of estrogen, parathyroid hormone 
or calcitonin through administration of these hormones 
directly or as a result of hormonal stimulants or depressants 
might be used to achieve the desired effect. 
While the invention has been described with a certain 
Treatment 
Item Control 
Steers, n 22 
Ca, µgig 14.2 








(P < 1) 
.02 
.02 
30 degree of particularity, it is manifest that many changes may 
be made in the details of construction and the arrangement 
of components without departing from the spirit and scope 
of this disclosure. It is understood that the invention is not 
limited to the embodiments set forth herein for purposes of 
Shear force, d 14 4.40 3.81 
Shear force, d 21 4.04 3.44 







35 exemplification, but is to be limited only by the scope of the 
claim or claims, including the fall range of equivalency to 
which each element thereof is entitled. 
Shear force > 4.6 kg, d 14 47.5 24.2 9.4 .09 
Shear force > 4.6 kg, d 21 32.5 10.0 8.5 .07 
µ-Calpain, activity/g .56 .19 .04 .05 
m-Calpain, activity/g .99 .62 .07 .07 
40 
Calpastatin, activity/g 4.83 4.11 .31 .04 
Activities of muscle µ-calpain, m-calpain and calpastatin 
measured at 24 hours postmortem from VITD3 supple- 45 
mented and control carcasses are reported in Table 4. Long-
issimus muscle samples from carcasses of VITD3 animals 
had lower (P<0.05) µ-calpain activities than controls. It may 
be noteworthy that in our study supplementation differences 
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What is claimed is: 
1. A method for improving meat tenderness in animals, 
comprising administering to said animal for a time prior to 
harvest an amount above that required nutritionally of 
5 Vitamin D, analogs or derivatives of Vitamin D, or combi-
nations thereof. 
2. The method according to claim 1, comprising admin-
istering the Vitamin D3 form of Vitamin D. 
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3. The method according to claim 1 comprising orally 
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Vitamin D, or combinations thereof, to said animal. 
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4. A method for improving meat tenderness in animals 
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tives of Vitamin D3 , or combinations thereof, to an animal 
15 in an amount above that required nutritionally by said 
animal for a time prior to harvest sufficient to activate or 
enhance postmortem tenderization mechanisms. 
5. The method according to claim 4, wherein said deriva-
tives of Vitamin D3 comprise hydroxylated metabolites of 
20 Vitamin D3 • 
6. The method according to claim 5, wherein said 
hydroxylated metabolites of Vitamin D3 are selected from 
the group consisting of 1-hydroxycholicalciferol, 
25-hydroxycholecalciferol, 1,25-dihydroxycholecalciferol, 




7. A method for improving meat tenderness in cattle, 
30 comprising administering to said animal for a time prior to 
harvest an amount above that required nutritionally of 
Vitamin D, analogs or derivatives of Vitamin D, or combi-
nations thereof. 
on the effectiveness of calcium chloride for improving 
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9. The method according to claim 8, comprising orally 
administering said dosage for a period of up to 10 days prior 
40 to harvest. 
10. The method according to claim 9, comprising orally 
administering Vitamin D3 • 
11. The method according to claim 7, comprising admin-
istering 1-10,000,000 IU daily of said Vitamin D, analogs or 
45 derivatives of Vitamin D, or combinations thereof. 
12. A meat product produced from an animal treated in 
accordance with one of the methods of claims 1-3 and 7-10. 
13. A composition for feeding to beef cattle comprising a 
feedstuff doped with 100,000 to 1,000,000 IU of Vitamin D, 
50 its analogs or derivatives, or combinations thereof, per 
kilogram of said feed stuff. 
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